Keywords: new, data, viracept, first-line, therapy, pfizer, protease

New data for Viracept as first-line therapy

Article | 15 June 2001

Print This

New data for Pfizer's protease inhibitor Viracept (nelfinavir), whichreinforces the benefit of the drug as a first-line therapy for HIV ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in